These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36430019)

  • 1. Side-Effects following Oxford/AstraZeneca COVID-19 Vaccine in Tororo District, Eastern Uganda: A Cross-Sectional Study.
    Onyango J; Mukunya D; Napyo A; Nantale R; Makoko BT; Matovu JKB; Wanume B; Okia D; Okello F; Okware S; Olupot-Olupot P; Lubaale Y
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36430019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study.
    Yesuf EA; Riad A; Sofi-Mahmudi A; Sudhakar M; Mekonnen A; Endalkachew S; Mama F; Muhidin S; Ayele B; Yahya M; Usman A; Abafita J; Klugar M
    Front Public Health; 2022; 10():937794. PubMed ID: 35928493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran.
    Soltani S; Matin BK; Gouya MM; Zahraei SM; Moradi G; Chehri O; Soofi M; Moradinazar M; Shadmani FK; Kalantari M; Khajeha H; Emamian MH; Najafi F
    BMC Public Health; 2023 Jul; 23(1):1415. PubMed ID: 37488541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking Side Effects of the COVID-19 Vaccine in Mymensingh District of Bangladesh.
    Khan MK; Ferdous J; Akhter S; Esha AM; Islam M
    Mymensingh Med J; 2022 Jan; 31(1):1-9. PubMed ID: 34999672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions following COVID-19 vaccine among healthcare professionals working in Ethiopia: a facility-based cross-sectional study.
    Asefa A; Derjachew N; Belete AM; Talargia F; Melese DM; Getachew B
    Front Public Health; 2023; 11():1187948. PubMed ID: 38026432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholera and COVID-19 pandemic prevention in multiple hotspot districts of Uganda: vaccine coverage, adverse events following immunization and WASH conditions survey.
    Bwire G; Kisakye A; Amulen E; Bwanika JB; Badebye J; Aanyu C; Nakirya BD; Okello A; Okello SA; Bukenya JN; Orach CG
    BMC Infect Dis; 2023 Jul; 23(1):487. PubMed ID: 37479986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy.
    Darweesh O; Khatab N; Kheder R; Mohammed T; Faraj T; Ali S; Ameen M; Kamal-Aldin A; Alswes M; Al-Jomah N
    PLoS One; 2022; 17(11):e0274526. PubMed ID: 36399454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Side Effects of the AstraZeneca COVID-19 Vaccine: A Multicenter Experience From Pakistan.
    Haider T; Ali J; Ali SM; Iftikhar AS; Siddiqui AA; Khan AS; Qamar JA; Sohail K; Anwar A; Hashmi AA
    Cureus; 2023 Oct; 15(10):e46543. PubMed ID: 37927680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to receive COVID-19 vaccines, associated factors and reasons for not taking a vaccine: a cross sectional study among persons aged 13-80 years in Wakiso, Central Uganda.
    Daama A; Rashid N; Asani K; Nalwoga GK; Nalugoda F; Bulamba R; Kyasanku E; Nakigozi G; Kigozi G; Kagaayi J; Mugamba S
    BMC Infect Dis; 2024 Apr; 24(1):391. PubMed ID: 38605355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intention to vaccinate against COVID-19 and adherence to non-pharmaceutical interventions against COVID-19 prior to the second wave of the pandemic in Uganda: a cross-sectional study.
    Wafula ST; Mugume IB; Sensasi B; Okware S; Chimbaru A; Nanyunja M; Talisuna A; Kabanda R; Bakyaita T; Wanyenze RK; Byakika-Tusiime J
    BMJ Open; 2022 Jun; 12(6):e057322. PubMed ID: 35654469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.
    Sønderskov KM; Dinesen PT; Østergaard SD
    Dan Med J; 2021 Mar; 68(5):. PubMed ID: 33870886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and comparison of post-vaccination adverse effects among Janssen and Oxford-AstraZeneca vaccinated adult individuals in Debre Tabor Town: A cross- sectional survey in Northwest Ethiopia.
    Chekol Abebe E; Mengie Ayele T; Tilahun Muche Z; Behaile T/Mariam A; Dagnaw Baye N; Mekonnen Agidew M; Asmamaw Dejenie T
    Hum Vaccin Immunother; 2022 Nov; 18(6):2104059. PubMed ID: 35960924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Vaccine: Side Effects After the First Dose of the Oxford AstraZeneca Vaccine Among Health Professionals in Low-Income Country: Ethiopia.
    Solomon Y; Eshete T; Mekasha B; Assefa W
    J Multidiscip Healthc; 2021; 14():2577-2585. PubMed ID: 34556992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Evaluation of Side-Effects Following the First Dose of Oxford/AstraZeneca COVID-19 Vaccine among Healthcare Workers in Saudi Arabia.
    Darraj MA; Al-Mekhlafi HM
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reported side-effects following Oxford/AstraZeneca COVID-19 vaccine in the north-west province, Iran: A cross-sectional study.
    Eterafi M; Fouladi N; Golizadeh M; Shaker H; Matin S; Safarzadeh E
    PLoS One; 2024; 19(1):e0296669. PubMed ID: 38181026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side effects of Sputnik V, Oxford-AstraZeneca, Sinopharm, and Covaxin and their associations with other variables among healthcare workers of a tertiary hospital in Iran.
    Oghazian S; Tavanaei Tamanaei T; Haghighi R; Faregh M; Oghazian MB
    Int Immunopharmacol; 2023 Apr; 117():109784. PubMed ID: 36812676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events following administration of COVID-19 vaccines in Saudi Arabia.
    Alqahtani S; Jokhdar H; Al-Tawfiq JA; Al-Otaibi S; Assiri A; Almudarra S; Alabdulkareem K; Haji A
    Sci Rep; 2022 Nov; 12(1):19551. PubMed ID: 36379996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.
    Rosero-Bixby L
    JMIR Public Health Surveill; 2022 May; 8(5):e35054. PubMed ID: 35483079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term COVID-19 vaccine adverse effects among adults in Ekiti State, Nigeria.
    Dele-Ojo BF; Adesokan A; Fadare JO; Ajayi PO; Raimi TH; Dada SA; Ojo OD; Ogunmodede JA; Ipinnimo TM; Ariyo OE; Godman B
    Curr Med Res Opin; 2024 Apr; 40(4):621-627. PubMed ID: 38323854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.